The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

The EU is in the process of introducing a new anti-money laundering (“AML”) and counter-terrorist financing (“CTF”) framework. The main elements of the new AML and CTF framework are: Broader scope: ...

The Financial Crimes Enforcement Network (FinCEN) and the federal banking agencies recently published the long-awaited notice of proposed rulemaking for the anti-money laundering/countering the ...

The open-label, first-in-human Phase I/Ib study is evaluating CER-1236's preliminary safety and efficacy in participants.

Panelists discuss how IDH inhibitors, particularly ivosidenib combined with azacitidine, represent potentially the greatest ...

Eating a nutritious diet can ensure you’re getting the nutrients your body needs to keep up your energy and support your immune system Good nutrition is important for everyone, but it can be difficult ...

Panelists discuss how venetoclax management requires standardized approaches to duration, bone marrow biopsy timing, growth factor use, and azole antifungal selection, with practices varying ...

Organizations must use AML in the banking sector to avoid any illegal activities and secure essential data. It’s much needed in the digital landscape as imposters are also using advanced illegal means ...

Although allogeneic hematopoietic cell transplantation (allo-HCT) remains the backbone of curative treatment for the majority of fit adults diagnosed with AML, there is indeed a subset of patients for ...

A cross-continental study suggests that in the treatment of acute myeloid leukemia, age affects survival, independent of ...

I see people saying “Bank Grade AML” in their marketing and promotions quite a bit lately. What’s it mean? Well, actually there is no defined standard for that, it’s not a real term. People use it to ...

Q3 2025 Management View James Dentzer, President and CEO, emphasized continued progress in the TakeAim Lymphoma study evaluating emavusertib in combination with ibrutinib in primary CNS lymphoma ...